MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Oculus Innovative Sciences Company Profile (NASDAQ:OCLS)

Consensus Ratings for Oculus Innovative Sciences (NASDAQ:OCLS) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.00 (25.56% downside)

Analysts' Ratings History for Oculus Innovative Sciences (NASDAQ:OCLS)
Show:
DateFirmActionRatingPrice TargetActions
6/17/2016Maxim GroupReiterated RatingBuy$3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for Oculus Innovative Sciences (NASDAQ:OCLS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016        
6/16/2016Q4($0.16)ViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2016Q216($0.07)($0.19)$3.56 million$3.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2015Q116($0.10)($0.15)$3.96 million$3.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/11/2015Q215($0.25)($0.11)$3.12 million$3.98 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/12/2015Q115($0.18)($0.69)$3.10 million$3.22 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q1 15($0.17)($0.01)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
6/12/2014Q4 14($0.21)$0.99$3.42 million$2.91 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/19/2013Q2($0.15)($0.21)$4.03 million$4.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2013Q1 2014($0.26)($0.26)$3.68 million$3.37 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/13/2013Q3 2013($0.08)($0.05)$3.28 million$3.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q312$0.03($0.05)$5.59 million$4.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Oculus Innovative Sciences (NASDAQ:OCLS)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Oculus Innovative Sciences (NASDAQ:OCLS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Oculus Innovative Sciences (NASDAQ:OCLS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
2/25/2016James J SchutzCEOBuy5,000$1.00$5,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2014James J SchutzCEOBuy6,285$1.78$11,187.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/16/2013James SchutzCEOBuy5,100$2.35$11,985.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2012Hojabr AlimiCEOBuy5,500$0.64$3,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/7/2012Hojabr AlimiCEOBuy5,300$0.65$3,445.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/9/2012James J SchutzCOOBuy13,000$0.80$10,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Oculus Innovative Sciences (NASDAQ:OCLS)
DateHeadline
06/28/16 03:25 PMOCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, -
06/27/16 05:32 PMSECFilings.com : Examines Oculus Innovative Sciences' Financial Results and Turnaround Plan
06/27/16 09:47 AMMarket Movers: The Charles Schwab Corporation (NYSE:SCHW), Oculus Innovative Sciences, Inc. (NASDAQ:OCLS ... - KC Register
06/27/16 08:38 AMSECFilings.com Examines Oculus Innovative Sciences' Financial Results and Turnaround Plan - [Marketwired] - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, takes a look at Oculus Innovative Sciences' recently announced fourth quarter and fiscal ...
06/27/16 06:03 AMSplits Calendar: Oculus Innovative Sciences splits before market open today (1:5 ratio) -
06/25/16 12:04 PMOCULUS INNOVATIVE SCIENCES, INC. Financials -
06/25/16 09:19 AMRevenue Update on Oculus Innovative Sciences(NASDAQ:OCLS) - TheFounders Daily
06/23/16 06:08 PMOculus Innovative Sciences : Announces Reverse Split of Common Stock
06/23/16 12:47 PMETF’s with exposure to Oculus Innovative Sciences, Inc. : June 23, 2016 -
06/22/16 05:29 PMOculus Innovative Sciences Announces Reverse Split of Common Stock - GlobeNewswire (press release)
06/22/16 05:29 PMOculus Innovative Sciences (OCLS) Announces One-for-Five Reverse Stock Split - StreetInsider.com
06/22/16 11:34 AMOculus Innovative Sciences, Inc. :OCLS-US: Earnings Analysis: Q4, 2016 By the Numbers : June 22, 2016 -
06/22/16 10:20 AMOculus Innovative Sciences (OCLS) Announces One-for-Five Reverse Stock Split
06/22/16 04:20 AM5:20 am Oculus Innovative Sciences announces 1-for-5 reverse split of its common stock will be effective after the close of business on June 24 -
06/22/16 04:09 AMOculus Innovative Sciences Announces Reverse Split of Common Stock - [at noodls] - Focus on Continued Growth in U.S. Dermatology Market While Expanding Potential Institutional Investor Base PETALUMA, Calif., June 22, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: ...
06/21/16 03:27 PMOCULUS INNOVATIVE SCIENCES, INC. Files SEC form 10-K, Annual Report -
06/20/16 07:13 AMAnalyst Views For The Week Ahead: Oculus Innovative Sciences, Inc. (OCLS) - Fiscal Standard
06/17/16 05:26 PMOculus Innovative Sciences (OCLS): Building a Commercial Presence - Maxim Group
06/17/16 10:59 AMEdited Transcript of OCLS earnings conference call or presentation 16-Jun-16 8:30pm GMT -
06/17/16 08:23 AMOculus Innovative Sciences' (OCLS) CEO Jim Schutz on Q4 2016 Results - Earnings Call Transcript
06/17/16 08:23 AMOculus Innovative Sciences FY16 revenues up 9%
06/16/16 05:48 PMOCULUS INNOVATIVE SCIENCES, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
06/16/16 05:48 PMOculus Innovative Sciences Inc Earnings Call (Q4 2016)
06/16/16 03:09 PMOCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme -
06/16/16 03:05 PMOculus Innovative Sciences Reports Financial Results for Fiscal Year 2016 and Fourth Quarter Ending March 31, 2016 - [GlobeNewswire] - Product Revenue for Fiscal Year 2016 Grew 31% Led by Growth in U.S. Conference Call Begins at 4:30pm EDT Today. PETALUMA, Calif., June 16, 2016-- Oculus Innovative Sciences, Inc., a specialty pharmaceutical ...
06/16/16 06:07 AMQ4 2016 Oculus Innovative Sciences Inc Earnings Release - After Market Close -
06/13/16 05:08 PMOculus Innovative Sciences, Inc. : annual earnings release
06/06/16 05:31 PMNew Broker Ratings For Oculus Innovative Sciences, Inc. (OCLS) - FTSE News
06/02/16 08:32 AMOculus Innovative Sciences Announces Financial Results for the Fiscal Year/Fourth Quarter 2016 and Conference Call - GlobeNewswire (press release) - Oculus Innovative Sciences Announces Financial Results for the Fiscal Year/Fourth Quarter 2016 and Conference CallGlobeNewswire (press release)PETALUMA, Calif., June 02, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), today announced that the financial results for its fiscal year and fourth quarter 2016, ended March 31, 2016, will be released after ...Insiders Are Gradually Buying Oculus Innovative Sciences, Inc. (NASDAQ:OCLS)HNNall 2 news articles »
06/02/16 03:25 AMOculus Innovative Sciences Announces Financial Results for the Fiscal Year/Fourth Quarter 2016 and Conference Call - [at noodls] - PETALUMA, Calif., June 02, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), today announced that the financial results for its fiscal year and fourth quarter 2016, ...
05/29/16 09:12 AMOculus Innovative Sciences, Inc. (NASDAQ:OCLS) Impact Score At 100 - Investor Newswire - Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Impact Score At 100Investor NewswireAlpha One explored various online articles released on Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), and it set a daily sentiment score of 0.171 on the company. The entity has an algorithm in place to know stock sentiment on the share after exploring ...and more »
05/29/16 09:12 AMOculus Innovative Sciences, Inc. (OCLS) Sees Large Decrease in Short Interest - Let Me Know About This - Oculus Innovative Sciences, Inc. (OCLS) Sees Large Decrease in Short InterestLet Me Know About ThisOculus Innovative Sciences logo Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) saw a significant decrease in short interest in the month of May. As of May 13th, there was short interest totalling 614,650 shares, a decrease of 18.5% from the April 29th ...
05/27/16 09:22 AMOculus Innovative Sciences, Inc. (NASDAQ:OCLS) Closes At $0.990 - RealistInvestor.com - Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Closes At $0.990RealistInvestor.comThe technical analysis of Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) stock highlights the stock is $0.002 points away +0.236% from its 50-day MA of $0.987. It is $-0.062 or -5.855% away $1.051, the 200-day Moving Average (MA) of stock. Yesterday ...Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Costs Of Goods Sold Stands At $6.566 MillionsEquities FocusInsiders Are Gradually Buying Oculus Innovative Sciences, Inc. (NASDAQ:OCLS)Wall Street Hints and NewsOculus Innovative Sciences Incorporated (NASDAQ:OCLS) Sellers Increased By 9.03% Their ShortsThe Postall 4 news articles »
05/20/16 09:45 AMInsiders Are Buying Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) - Wall Street Hints and News - Insiders Are Buying Oculus Innovative Sciences, Inc. (NASDAQ:OCLS)Wall Street Hints and NewsAccording to the latest SEC filings, insiders at Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) have increased their position in the stock by 6.50%. Insiders now own 0.40% of total outstanding shares. There are both legal and illegal types of insider ...and more »
05/20/16 09:45 AMOculus Innovative Sciences, Inc. (NASDAQ:OCLS) Comprehensive Income At $-3.507 - RealistInvestor.com - Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Comprehensive Income At $-3.507RealistInvestor.comFor the year ended 2015-03-31, Oculus Innovative Sciences, Inc. (NASDAQ:OCLS)comprehensive income was $-3.507 millions whereas for the quarter ended 2015-03-31, it was $-3.507 millions. Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) posted ...
05/17/16 05:11 PMCan virtual reality translate into real profits? -
05/12/16 11:35 PMOculus Innovative Sciences, Inc. (NASDAQ:OCLS) Comprehensive Income At $-3.507 For Period Ended 2015-03-31 - RealistInvestor.com - Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Comprehensive Income At $-3.507 For Period Ended 2015-03-31RealistInvestor.comFor the year ended 2015-03-31, Oculus Innovative Sciences, Inc. (NASDAQ:OCLS)comprehensive income was $-3.507 millions while for the quarter ended 2015-03-31, it was $-3.507 millions. Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) posted ...and more »
05/11/16 06:30 PMOculus Innovative Sciences Incorporated (NASDAQ:OCLS) Sellers Covered 8.2% of Their Shorts - B.O.D.Y Confidential - Oculus Innovative Sciences Incorporated (NASDAQ:OCLS) Sellers Covered 8.2% of Their ShortsB.O.D.Y ConfidentialThe ratio is positive, as 1 funds sold all Oculus Innovative Sciences, Inc. shares owned while 4 reduced positions. 4 funds bought stakes while 4 increased positions. They now own 1.55 million shares or 154.24% more from 610,144 shares in 2015Q3.
05/09/16 04:49 AMNext Weeks Broker Price Targets For Oculus Innovative Sciences, Inc. (OCLS) - Share Trading News - Next Weeks Broker Price Targets For Oculus Innovative Sciences, Inc. (OCLS)Share Trading News04/20/2016 – Oculus Innovative Sciences, Inc. had its “buy” rating reiterated by analysts at Maxim Group. They now have a USD 3 price target on the stock. 05/01/2015 – Oculus Innovative Sciences, Inc. had its “hold” rating reiterated by analysts at Zacks.
05/07/16 05:38 PMOculus Innovative Sciences Incorporated (NASDAQ:OCLS) Short Interest Decreased By 8.2% - B.O.D.Y Confidential - Oculus Innovative Sciences Incorporated (NASDAQ:OCLS) Short Interest Decreased By 8.2%B.O.D.Y ConfidentialThe short interest to Oculus Innovative Sciences Incorporated's float is 3.96%. The stock decreased 0.98% or $0.01 on May 6, hitting $1.01. About 160,349 shares traded hands. Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) has declined 18.55% since ...
05/06/16 06:21 PMOculus Innovative Sciences, Inc. (NASDAQ:OCLS) Comprehensive Income At $-3.899 Millions For Quarter Closed ... - RealistInvestor.com - Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Comprehensive Income At $-3.899 Millions For Quarter Closed ...RealistInvestor.comFor the year ended 2015-12-31, Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) comprehensive income was $-3.899 millions whereas for the quarter ended 2015-12-31, the comprehensive income was $-3.899 millions. Oculus Innovative Sciences, Inc.and more »
05/05/16 06:40 PMBroker Roundup For Oculus Innovative Sciences, Inc. (OCLS) - Share Trading News - Broker Roundup For Oculus Innovative Sciences, Inc. (OCLS)Share Trading NewsThe share price of Oculus Innovative Sciences, Inc. (OCLS) was up +0.98% during the last trading session, with a day high of 1.06. 450240 shares were traded on Oculus Innovative Sciences, Inc.'s last session. The stock's 50 day moving average is 0.97 ...Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) Comprehensive Income At $-3.899 Millions For Quarter Closed ...RealistInvestor.comall 2 news articles »
05/03/16 05:00 AMOculus Innovative Sciences Launches New Ceramax™ Skin Barrier Cream in the United States - GlobeNewswire (press release) - Oculus Innovative Sciences Launches New Ceramax™ Skin Barrier Cream in the United StatesGlobeNewswire (press release)PETALUMA, Calif., May 03, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and ...and more »
05/03/16 03:30 AMOculus Innovative Sciences Launches New Ceramax™ Skin Barrier Cream in the United States - [at noodls] - PETALUMA, Calif., May 03, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment ...
04/28/16 06:44 PMOculus Innovative Sciences, Inc. (NASDAQ:OCLS) EBITDA Yearly Stands At $-6.406 Millions - RealistInvestor.com - Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) EBITDA Yearly Stands At $-6.406 MillionsRealistInvestor.comFor the period ended 2015-03-31, Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) comprehensive income was $-3.507 millions. For the three-month closed 2015-03-31, the comprehensive income was $-3.507 millions. Oculus Innovative Sciences, Inc.
04/28/16 06:44 PMOculus Innovative Sciences, Inc. (OCLS) Updated Broker Price Targets - Share Trading News - Oculus Innovative Sciences, Inc. (OCLS) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Oculus Innovative Sciences, Inc. (OCLS). The latest reports which are currently in issue on Thursday 28th of April state 0 analysts have a rating of “strong buy”, 0 ...and more »
04/28/16 04:53 AMOculus Innovative Sciences to Present at Pioneers 2016 Investor Conference Hosted by Joseph Gunnar & Company in ... - Nasdaq - Oculus Innovative Sciences to Present at Pioneers 2016 Investor Conference Hosted by Joseph Gunnar & Company in ...NasdaqPETALUMA, Calif., April 28, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and ...Oculus Innovative Sciences Incorporated (NASDAQ:OCLS) Sellers Covered 9.84% of Their ShortsB.O.D.Y Confidentialall 4 news articles »
04/28/16 03:31 AMOculus Innovative Sciences To Present At Pioneers 2016 Investor Conference Hosted By Joseph Gunnar & Company In New York City - PETALUMA, Calif., April 28, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue ...
04/27/16 06:36 PMOculus Innovative Sciences Incorporated (NASDAQ:OCLS) Sellers Covered 9.84% of Their Shorts - B.O.D.Y Confidential - Oculus Innovative Sciences Incorporated (NASDAQ:OCLS) Sellers Covered 9.84% of Their ShortsB.O.D.Y ConfidentialThe short interest to Oculus Innovative Sciences Incorporated's float is 4.31%. The stock is down 3.96% or $0.04 after the news, hitting $0.97 per share. About 409,202 shares traded hands. Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) has declined ...and more »
04/27/16 06:36 PMOculus Innovative Sciences to Present at the Third Annual Growth Capital Expo MicroCap Investor Conference in Las ... - Nasdaq - Oculus Innovative Sciences to Present at the Third Annual Growth Capital Expo MicroCap Investor Conference in Las ...NasdaqPETALUMA, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) (NASDAQ:OCLSW), a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and ...and more »
About Oculus Innovative Sciences

Oculus Innovative Sciences logoOculus Innovative Sciences, Inc. is a specialty device and pharmaceutical company. The Company develops and markets solutions for the treatment of dermatological conditions and advanced tissue care in both humans and animals. The Company offers wound care products which are sold into the human and animal healthcare markets in the United States, Mexico and Europe. The Company also operates a microbiology contract testing laboratory division that provides consulting and laboratory services to medical companies that design and manufacture biomedical devices and drugs, as well as testing of products and the Company's products. The Company's key technology, Microcyn is based on electrically charged oxychlorine small molecules designed to target a range of pathogens that cause disease. The Company completed Phase II trials for Microcyn technology.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: OCLS
  • CUSIP:
Key Metrics:
  • Previous Close: $4.03
  • 50 Day Moving Average: $4.79
  • 200 Day Moving Average: $5.05
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $84.63M
  • Current Quarter EPS Consensus Estimate: $-0.37 EPS
Additional Links:
Oculus Innovative Sciences (NASDAQ:OCLS) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha